Table 1.
Parameters correlating with CHF progression within 48 weeks after STEMI.
| Variable | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| RR (95% CI) | p | RR (95% CI) | p | |
| Pathological TO | 2.75 (1.191–6.326) | 0.018 | - | - |
| Pathological HRT | 2.64 (1.17–5.92) | 0.019 | 3.92 (1.66–9.25) | 0.0018 |
| SDANN | 0.98 (0.97–1.0) | 0.11 | - | - |
| HfP | 1.0 (0.99–1.01) | 0.22 | - | - |
| BNP | 1.001 (1.0001–1.0002) | 0.023 | - | - |
| ESD | 1.04 (1.01–1.07) | 0.0022 | 1.04 (1.015–1.07) | 0.0027 |
| GLS | 0.89 (0.82–0.98) | 0.017 | 0.9 (0.815–0.98) | 0.028 |
| GCS | 0.92 (0.86–0.98) | 0.01 | - | - |
| GRS | 0.95 (0.92–0.99) | 0.012 | - | - |
Note: BNP—brain natriuretic peptide; HfP—high-frequency component of the spectrum; SDANN—standard deviation of the average values of sinus RR intervals for 5 min; TO—turbulence onset; ESD—end-systolic dimension; RR—relative risk; HRT—heart rate turbulence. The values are given with 95% CI.